Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
recent articles
From the Lumea blog: Digital transformation is reshaping industries across the globe, and pathology is no exception. While much of the “dig path” buzz centers around the potential of artificial intelligence (AI) as a diagnostic aid,...
Learn how Tribun Health and Ibex are integrating AI-powered digital pathology to improve diagnoses, streamline workflows, and support pathologists globally. Artificial intelligence is gradually becoming a practical tool for healthcare,...
Harrison.ai: Company’s Radiology and Pathology Solutions Expand Clinician Capacity, Increase Operational Efficiency, and Improve Early Disease Diagnosis February 11, 2025 10:00 AM Eastern Standard Time BOSTON--(BUSINESS...
Ibex: FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer diagnostics February 10, 2025 08:05 AM Eastern Standard Time BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in...
Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced the latest advancement in its automated quality control (QC)...
Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, is thrilled to announce the integration of its NephroPath AI tools into HistoWiz’s PathologyMap™ platform....
